Alex N. Pearson

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 04, 2024

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 08, 2023

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer.

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer.

Journal: Cancer discovery

Published: December 21, 2022

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.

Journal: Cancer discovery

Published: April 30, 2020

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.

Journal: JCO precision oncology

Published: October 03, 2019

Radio-frequency optomechanical characterization of a silicon nitride drum.

Radio-frequency optomechanical characterization of a silicon nitride drum.

Journal: Scientific reports

Published: September 25, 2019

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.

Journal: Nature communications

Published: July 18, 2019

Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.

Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 09, 2019

Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.

Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 12, 2018

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment.

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 28, 2018

Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.

Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.

Journal: British journal of cancer

Published: May 23, 2018

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.

Journal: Breast cancer research and treatment

Published: January 05, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026